메뉴 건너뛰기
Molecular Neurodegeneration
Volumn 2, Issue 1, 2007, Pages
From a Parkinson's disease expert: Rasagiline and the future of therapy
Author keywords

[No Author keywords available]
Indexed keywords

EID: 34547554337     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-2-13     Document Type: Article
Times cited : (10)
References (6)
  • 1
    • 0027196161 scopus 로고    scopus 로고
    • Chronic inhibition of monoamine oxidase type A increases noradrenaline release in rat frontal cortex
    • Finberg JPM, Pacak K, Kopin IJ, Goldstein DS: Chronic inhibition of monoamine oxidase type A increases noradrenaline release in rat frontal cortex. Naunyn-Schmiedeberg's Arch Pharmacol 2003, 347(5):500-505.
    • (2003) Naunyn-Schmiedeberg's Arch Pharmacol , vol.347 , Issue.5 , pp. 500-505
    • Finberg, J.P.M.1    Pacak, K.2    Kopin, I.J.3    Goldstein, D.S.4
  • 2
    • 0019944455 scopus 로고
    • Relationship between tyramine potentiation and selective inhibition of MAO types A and B in the rat vas deferens
    • Finberg JPM, Tenne M: Relationship between tyramine potentiation and selective inhibition of MAO types A and B in the rat vas deferens. Brit J Pharmacol 1982, 77:13-21.
    • (1982) Brit J Pharmacol , vol.77 , pp. 13-21
    • Finberg, J.P.M.1    Tenne, M.2
  • 3
    • 0029832455 scopus 로고    scopus 로고
    • The effect of long term treatment with monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo
    • Lamensdorf I, Youdim MBH, Finberg JPM: The effect of long term treatment with monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo. J Neurochem 1996, 67:1532-1539.
    • (1996) J Neurochem , vol.67 , pp. 1532-1539
    • Lamensdorf, I.1    Youdim, M.B.H.2    Finberg, J.P.M.3
  • 4
    • 0032498811 scopus 로고    scopus 로고
    • Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor
    • Finberg JPM, Takeshima T, Johnston JM, Commissiong JW: Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor. Neuroreport 1998, 9:703-707.
    • (1998) Neuroreport , vol.9 , pp. 703-707
    • Finberg, J.P.M.1    Takeshima, T.2    Johnston, J.M.3    Commissiong, J.W.4
  • 5
    • 34547500318 scopus 로고    scopus 로고
    • Characterisation of neuroprotective effect of rasagiline in cerebellar granule cells
    • Bonneh-Barkay D, Ziv N, FinbergJPM: Characterisation of neuroprotective effect of rasagiline in cerebellar granule cells. Neuropharmacology 2004, 47:72-80.
    • (2004) Neuropharmacology , vol.47 , pp. 72-80
    • Bonneh-Barkay, D.1    Ziv, N.2    Finberg, J.P.M.3
  • 6
    • 34250890348 scopus 로고    scopus 로고
    • Modification of L-DOPA pharmacological activity by MAO inhibitors
    • in press
    • Finberg JPM, Sader-Mazbar O: Modification of L-DOPA pharmacological activity by MAO inhibitors. J Neural Transm 2007 in press.
    • (2007) J Neural Transm
    • Finberg, J.P.M.1    Sader-Mazbar, O.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.